Global Methamphetamine Market Research Report - Segmentation by Route of Administration (Oral, Smoking, Snorting, Injecting); Application (Attention Deficit Hyperactivity Disorder (ADHD), Obesity, Narcolepsy, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); Region Forecast 2024 - 2030

Market Size and Overview:

Global Methamphetamine Market is estimated to be worth USD 590.03 Million in 2023 and is projected to reach a value of USD 881.34 Million by 2030, growing at a CAGR of 5.9% during the forecast period 2024-2030.

Methamphetamine, a potent and highly addictive stimulant with profound effects on the central nervous system, manifests as a colorless and odorless powder readily soluble in water or alcohol. Originating from amphetamine, its initial applications were in nasal decongestants and inhalers. Methamphetamine elicits heightened activity, increased talkativeness, decreased appetite, and a pleasurable sense of well-being. In comparison to amphetamine, it exerts a more insidious influence on the brain, displaying greater potency and resulting in prolonged and more detrimental consequences on the central nervous system. These characteristics render methamphetamine highly susceptible to widespread misuse and addiction.

When consumed through ingestion, inhalation, or injection, methamphetamine induces a potent high with intense effects. Users experience heightened energy and euphoria, erroneously believing it allows for extended activity. However, repeated usage leads to severe physical and neurological damage. Adverse effects include palpitations, hypertension, accelerated respiration, sedation, headaches, vision impairment, dry mouth, and lightheadedness. Its appetite-suppressing properties make it a perilous weight-loss strategy, and the risk of "Meth mouth" involves severe tooth decay and gum disease. Prolonged use results in brain damage affecting memory, motor functions, mood, and promoting aggression. Higher doses can lead to fever, confusion, convulsions, and even fatality.

Global Methamphetamine Market Dynamics:

The growth of the Global Methamphetamine Market is propelled by the pleasurable effects of methamphetamine.

Methamphetamine is commonly consumed through smoking, snorting, injection, or oral ingestion. Smoking or injecting provides a swift and powerful rush, snorting induces euphoria within minutes, and oral ingestion takes around 15-20 minutes for effects to manifest. The drug's effects last for hours, with a clearance time of up to 4 days from the body. Sought after for its pleasurable effects, including heightened attentiveness, increased physical activity, suppressed appetite, and an enhanced sense of well-being, methamphetamine's unique characteristic of remaining unchanged in the body for an extended duration extends its stimulant effects, driving demand.

The escalating demand for methamphetamine as a treatment for ADHD contributes to the Global Methamphetamine Market's growth.

Methamphetamine hydrochloride, known as Desoxyn, is prescribed for attention deficit hyperactivity disorder (ADHD). Acting by altering natural substances in the brain, it falls under the stimulant category. Its purpose is to enhance concentration, focus, and behavioral management. Additionally, Desoxyn aids in task organization and improves listening proficiency, further fueling the demand for methamphetamine.

Challenges in the Global Methamphetamine Market:

The Global Methamphetamine Market faces challenges primarily related to addiction and dependence. Methamphetamine presents a substantial risk of misuse and rapid development of tolerance. Due to its impact on dopamine levels, it is highly addictive. Prolonged use hinders natural dopamine production, leading to dependence for normalcy. Increasing doses become necessary to achieve desired effects, inhibiting the market's growth.

Global Methamphetamine Market Opportunities:

Opportunities for market expansion emerge prominently in the Global Methamphetamine Market. The escalating demand for Desoxyn (methamphetamine hydrochloride) is driven by its growing applications in specific medical conditions, such as ADHD, exogenous obesity, and narcolepsy. Companies specializing in Desoxyn production can leverage this prospect by diversifying their product offerings to countries with a higher prevalence of these conditions, including Spain, France, Northern Ireland, and Mexico. This strategic expansion not only broadens the customer base but also contributes significantly to overall revenue growth.

COVID-19 Impact on the Global Methamphetamine Market:

The Global Methamphetamine Market has experienced significant repercussions due to the COVID-19 outbreak. The stringent lockdowns, travel restrictions, and social distancing measures resulted in a diminished demand for methamphetamine. The closure of international borders disrupted global supply chains, and local supply and acquisition of illicit drugs were hampered by physical distancing measures and increased policing. The pandemic's influence on the market's supply chain led to delays in the efficient production and distribution of methamphetamine, contributing to an adverse impact on market growth.

Global Methamphetamine Market Recent Developments:

In June 2023, Researchers at Alameda Health System's Bridge Clinic disclosed their participation in a groundbreaking trial conducted across six cities. The trial aims to explore the use of injectable buprenorphine in treating adults with co-occurring methamphetamine use disorder and opioid addiction.

In June 2022, Canada announced the decriminalization of small quantities of hard drugs as part of a pilot project in British Columbia. The primary objective of this project is to address the opioid crisis, which has tragically claimed numerous lives. Rather than punitive measures for drug possession, the project prioritizes addiction treatment as an effective approach to tackling the issue.

Global Methamphetamine Market Segmentation: By Route of Administration

1. Oral
2. Smoking
3. Snorting
4. Injecting

The Oral segment secured the highest market share in 2022, attributed to the convenience, non-invasiveness, and cost-effectiveness of administering Desoxyn (methamphetamine hydrochloride) medications orally. These tablets are employed to address medical conditions such as ADHD, exogenous obesity, and narcolepsy. In ADHD cases, it enhances attention while reducing impulsive and hyperactive behaviors. For obesity, it acts as an appetite suppressant, and for narcolepsy, it elevates alertness while reducing daytime drowsiness.

Global Methamphetamine Market Segmentation: By Application

1. Attention Deficit Hyperactivity Disorder (ADHD)
2. Obesity
3. Narcolepsy
4. Others

The Attention Deficit Hyperactivity Disorder (ADHD) segment held the highest market share in 2022, driven by the increasing use of Desoxyn (methamphetamine hydrochloride) for ADHD treatment. Desoxyn, classified as a stimulant drug, modifies levels of specific natural substances in the brain, aiming to enhance concentration, aid in task focus, and address associated behavioral problems. Additionally, Desoxyn may contribute to task organization and improved listening skills.

Global Methamphetamine Market Segmentation: By Distribution Channel

1. Hospital Pharmacies
2. Retail Pharmacies
3. Online Pharmacies

The Retail Pharmacies segment dominated the market in 2022, credited to the convenience they offer in accessing medications like Desoxyn (methamphetamine hydrochloride) prescribed for conditions such as ADHD. Retail pharmacies provide hassle-free access, ensuring easy availability for patients in need. Moreover, these channels assure a regulated and controlled environment, adhering to legal and regulatory requirements for the safe and responsible dispensing of Desoxyn.

Global Methamphetamine Market Segmentation: By Region

1. North America
2. Europe
3. Asia-Pacific
4. South America
5. Middle East & Africa

North America emerged as the leader in the Global Methamphetamine Market in 2022. Factors contributing to this dominance include the high prevalence of methamphetamine use and addiction, a growing incidence of medical conditions like ADHD, obesity, and narcolepsy, and the increasing decriminalization of methamphetamine in various states within the United States and Canada. Additionally, North America houses key market players, such as Mylan N.V., Abbott Alkaloidal Company, Veranova, L.P., Ovation Pharmaceuticals, Inc., and Key Therapeutics, LLC.

The European region is expected to witness the fastest growth during the forecast period (2023-2030). This growth is attributed to the increasing demand for Desoxyn in treating medical conditions, a well-established regulatory framework supporting methamphetamine availability, and the presence of major market players, including Recordati S.p.A. and Hikma Pharmaceuticals plc.

Global Methamphetamine Market Key Players:

1. Mylan N.V. (United States)
2. Sigma-Aldrich (United States)
3. Abbott Alkaloidal Company (United States)
4. Recordati S.p.A. (Italy)
5. Veranova, L.P. (United States)
6. Ovation Pharmaceuticals, Inc. (United States)
7. Dr. Reddy's Laboratories Ltd. (India)
8. Key Therapeutics, LLC (United States)
9. Hikma Pharmaceuticals plc (United Kingdom)
10. Norac Pharma, Inc. (United States)